Emergent Biosolutions Inc (EBS)
Accounts Payable
$50.20M
Quarterly · Period ending: · USD
EBS Accounts Payable
Latest reported$50.20Mperiod ending
Latest reported$50.20Mperiod ending
EBS Quarterly Accounts Payable ($103.50M → $50.20M)
Quarterly accounts payable
High-resolution chart · PNG
EBS accounts payable history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Accounts Payable (USD) |
|---|---|
| 50,200,000 | |
| 39,500,000 | |
| 55,600,000 | |
| 57,400,000 | |
| 63,700,000 | |
| 58,100,000 | |
| 60,900,000 | |
| 82,100,000 | |
| 95,900,000 | |
| 100,200,000 | |
| 112,200,000 | |
| 112,700,000 | |
| 108,300,000 | |
| 124,200,000 | |
| 103,500,000 | |
| 103,800,000 | |
| 106,200,000 | |
| 107,300,000 | |
| 128,900,000 | |
| 135,200,000 | |
| 151,800,000 | |
| 142,200,000 | |
| 136,100,000 | |
| 102,800,000 | |
| 84,800,000 | |
| 84,200,000 | |
| 94,800,000 | |
| 91,300,000 | |
| 124,500,000 | |
| 78,600,000 | |
| 80,700,000 | |
| 38,874,000 | |
| 41,629,000 | |
| 46,216,000 | |
| 41,751,000 | |
| 30,111,000 | |
| 29,604,000 | |
| 27,179,000 | |
| 34,649,000 | |
| 46,342,000 | |
| 58,974,000 | |
| 45,611,000 | |
| 37,970,000 | |
| 41,248,000 | |
| 41,824,000 | |
| 40,583,000 | |
| 40,930,000 | |
| 39,351,000 | |
| 36,968,000 | |
| 36,643,000 | |
| 27,521,000 | |
| 29,018,000 | |
| 25,711,000 | |
| 23,871,000 | |
| 31,297,000 | |
| 27,348,000 | |
| 23,301,000 | |
| 28,316,000 | |
| 40,530,000 | |
| 33,902,000 | |
| 32,182,000 | |
| 24,034,000 | |
| 25,409,000 | |
| 22,518,000 | |
| 20,300,000 | |
| 16,164,000 | |
| 17,159,000 | |
| 21,236,000 | |
| 17,568,000 | |
| 17,186,000 | |
| 18,254,000 | |
| 16,673,000 | |
| 19,933,000 | |
| 17,863,000 | |
| 17,979,000 | |
| 19,383,000 | |
| 17,347,000 | |
| 19,003,000 | |
| 27,366,000 | |
| 16,571,000 | |
| 10,425,000 | |
| 5,520,000 | |
| 128,900,000 | |
| 103,500,000 |